S&P 500 7,575 +1.23% Nasdaq 26,282 +1.74% Dow Jones 52,637 -0.50% FTSE 100 10,497 -1.70% DAX 25,067 -2.76% Nikkei 225 68,558 -1.69% Hang Seng 24,175 +3.53% WTI Crude 71.41 +1.38% Gold 4,114 -0.76% US 10-Year Treasury Yield 4.569 +2.01% S&P 500 7,575 +1.23% Nasdaq 26,282 +1.74% Dow Jones 52,637 -0.50% FTSE 100 10,497 -1.70% DAX 25,067 -2.76% Nikkei 225 68,558 -1.69% Hang Seng 24,175 +3.53% WTI Crude 71.41 +1.38% Gold 4,114 -0.76% US 10-Year Treasury Yield 4.569 +2.01%

LATEST

Five Guys to open in Beijing as more US chains hunger for success in China●Market trading guide: CDSL among 2 stock recommendations for Monday●New data reveal 10 U.S. cities with worst credit card delinquency●James Murdoch may have reaped as much as $7.5 billion from his pre-IPO investment in Elon Musk’s SpaceX●Mcap of 4 of top-10 most valued firms jumps ₹92,995 cr; HDFC Bank, Airtel top gainers●Top Performing Pet Insurance Stocks●Best AI Stocks●Top Performing Green Penny Stocks●Five Guys to open in Beijing as more US chains hunger for success in China●Market trading guide: CDSL among 2 stock recommendations for Monday●New data reveal 10 U.S. cities with worst credit card delinquency●James Murdoch may have reaped as much as $7.5 billion from his pre-IPO investment in Elon Musk’s SpaceX●Mcap of 4 of top-10 most valued firms jumps ₹92,995 cr; HDFC Bank, Airtel top gainers●Top Performing Pet Insurance Stocks●Best AI Stocks●Top Performing Green Penny Stocks●

Europe

Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod

Business | Euronews RSS · 30 Jun 2026 · 🇫🇷 France

Abivax shares jump 36% as new trial data support ulcerative colitis drug obefazimod

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.

Read the full story at Business | Euronews RSS →

EUROS aggregates the world's financial press. The full article lives with the newsroom that reported it.

More Europe

Iran-Oman Hormuz talks overtaken by escalation as Tehran closes strait

bne IntelliNews · 1h ago

Korean market expects unanimous BoK rate rise

bne IntelliNews · 13h ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

Europe News · 2d ago

EasyJet pops 13% as airline weighs $7.7 billion rival takeover bid from Apollo

Europe News · 2d ago